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Background: CLC-K channels and their subunit barttin are crucial for urinary concentration and hearing.
Results:Non-palmitoylated barttin mutants reduce CLC-K current amplitudes without modifying unitary channel properties.
Conclusion: Palmitoylation of barttin switches CLC-K channels into an active state.
Significance: Palmitoylation/depalmitoylation of CLC-K/barttin channels pre-inserted in epithelial plasma membranes might
regulate renal chloride absorption.
CLC-K/barttin chloride channels are essential forNaCl re-ab-
sorption inHenle’s loop and for potassium secretion by the stria
vascularis in the inner ear. Here, we studied the posttransla-
tional modification of such channels by palmitoylation of their
accessory subunit barttin. We found that barttin is palmitoy-
lated in vivo and in vitro and identified two conserved cysteine
residues at positions 54 and 56 as palmitoylation sites. Point
mutations at these two residues reduce themacroscopic current
amplitudes in cells expressing CLC-K/barttin channels propor-
tionally to the relative reduction in palmitoylated barttin. CLC-
K/barttin expression, plasma membrane insertion, and single
channel properties remain unaffected, indicating that these
mutations decrease the number of active channels. R8W and
G47R, two naturally occurring barttin mutations identified in
patients with Bartter syndrome type IV, reduce barttin palmi-
toylation andCLC-K/barttin channel activity. Palmitoylation of
the accessory subunit barttin might thus play a role in chloride
channel dysfunction in certain variants of Bartter syndrome.
We did not observe pronounced alteration of barttin palmi-
toylation upon increased salt and water intake or water dep-
rivation, indicating that this posttranslational modification
does not contribute to long term adaptation to variable water
intake. Our results identify barttin palmitoylation as a novel
posttranslational modification of CLC-K/barttin chloride
channels.
Barttin is the accessory subunit of CLC-K chloride channels
expressed in the kidney and the inner ear (1–4). There are two
types of human CLC-K channels (5): hClC-Ka, which resides in
the thin ascending limb of Henle’s loop and contributes to the
counter-current mechanism (6), and hClC-Kb, which is neces-
sary for secondary-active sodium chloride re-absorption in the
outer medulla and cortical region of the kidney (7). hClC-Ka
and hClC-Kb are also expressed in themarginal cells of the stria
vascularis in the inner ear and contribute to potassium secre-
tion into the endolymph, a process that is crucial for sensory
transduction in inner hair cells (1, 8).
Barttin was identified as a product of the disease gene of
Bartter syndrome type IV, a human syndrome that combines
sensorineural deafness with urinary concentration deficit (9).
Barttin is an integral membrane protein that modifies the func-
tion aswell as the subcellular distribution ofCLC-K channels. It
promotes surface membrane insertion of CLC-K/barttin chan-
nels, increases protein stability, and switches human CLC-K/
barttin channels into an active state (1, 10–13). Urinary con-
centration mechanisms have to be regulated to permit the
adjustment of renal water excretion to changes in water intake.
The chloride permeability in the thin and thick ascending loop
of Henle is a major determinant of the cortico-medullary
osmotic gradient that determines the osmolarity of the urine.
Regulation of CLC-K/barttin channels might thus be involved
in adjusting water excretion and intake, and one potential tar-
get for posttranslational modification is the accessory subunit
barttin with its multiple functional effects on CLC-K/barttin
channels. Posttranslational modification of ion channels by
palmitoylation has been shown to affect channel functions such
as gating and pharmacology (14–18). Moreover, palmitoyla-
tion is known to regulate subcellular trafficking of integral
membrane proteins (19–22) or to increase the affinity of cer-
tain proteins to specific micro-domains such as lipid rafts
within the cell membrane (19, 23–26).
Palmitoylation is a covalent attachment of long chain fatty
acids (i.e. palmitate) to a cysteine residue(s) within the protein
via a labile thioester linkage (19, 27). Here, we study palmitoy-
lation of barttin as a potential regulatory pathway and charac-
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terize the effects of barttin palmitoylation on CLC-K/barttin
channel function. Our data show that palmitoylation of barttin
is necessary for activation of plasma membrane-inserted CLC-
K/barttin channels.
Experimental Procedures
Heterologous Expression and Mutagenesis—We used heter-
ologous expression in two different cell lines, MDCK II4 and
HEK293T cells, to study intracellular trafficking and function
of hClC-Ka/barttin and hClC-Kb/barttin (12, 13, 28, 29). CLC-
K/barttin function and subcellular distribution are comparable
in both systems (12, 30), and both systems are well suited for
biochemical analyses. However, HEK293T cells robustly
express CLC-K/barttin and are thus perfect for the functional
characterization of mutations that decrease macroscopic cur-
rent amplitudes. MDCK II cells are an established model sys-
tem to study targeting in epithelial cells. HEK293T andMDCK
II cells were transfected with plasmids DNA encoding hClC-
Ka, hClC-Kb, or human barttin (12, 28) using the calciumphos-
phate precipitation method (31) or Lipofectamine 2000 (Invit-
rogen). In some of the experiments CFP or YFP fusion proteins
of CLC-K channels and barttin were transfected (28). Mutant
barttins were constructed using the QuikChange site-directed
mutagenesis kit (Stratagene, La Jolla, CA). For all constructs,
PCR-amplified sequences were verified by direct sequencing,
and two independent mutant clones were used for expression
studies.
Analysis of Barttin Palmitoylation—Palmitoylation of heter-
ologously expressed barttin was investigated after transient
transfection of HEK293T cells with pcDNA3.1 plasmid DNA
encoding for human barttin-mCFP fusion protein. For experi-
ments using radioactive palmitate, transfected HEK293T cells
were labeledwith [3H]palmitate (300Ci/ml, 30–60Ci/mmol)
for 2 h 1 day after transfection. Barttin-mCFPwas immunopre-
cipitated with anti-GFP antibodies (rabbit polyclonal to GFP;
GeneTex), and radiolabeled polypeptides were analyzed by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) on 10% acrylamide gels under non-reducing con-
ditions followed by fluorography.
A modified protocol for proteomic acyl-biotinyl exchange
(ABE) (32) was used to analyze palmitoylation of barttin in
native tissue.After homogenization ofmouse kidneys, free thiol
groups were blocked by treatment with 10 mMN-ethylmaleim-
ide. Thioester-linked palmitoyl moieties were then cleaved by
treatmentwith 0.5Mhydroxylamine (plusNH2OH) followed by
labeling of the free thiol groups with 0.75 mM thiol-reactive
biotinylation reagent (HPDP-biotin). Biotinylated proteins
were purified by streptavidin-agarose affinity chromatography,
subjected to SDS-PAGE on 10% acrylamide gels, and identified
by Western blot with anti-barttin antibody (sc-49611; Santa
Cruz Biotechnology). Samples without hydroxylamine treat-
ment (minus NH2OH) served to identify unspecific binding of
biotin.
To analyze the palmitoylation of heterologously expressed
barttin-mCFP, cells were subjected to ABE followed by immu-
noprecipitation of barttin-mCFPwith anti-GFP-Sepharose and
Western blot with anti-biotin-specific antibody allowing for
specific detection of palmitoylated protein. Samples without
NH2OH were used as the negative control. Barttin palmitoyla-
tion levels were defined by densitometric analysis of barttin
protein bands after (“plus NH2OH”) or without hydroxylamine
treatment (“minus NH2OH” bands). After normalization to the
corresponding expression levels, as defined by theWestern blot
of total lysates, values from the samples without NH2OH treat-
ment were subtracted from corresponding values obtained in
samples treated with NH2OH to correct for unspecific signals.
For every barttin mutant, palmitoylation level was given as rel-
ative value in comparison toWTbarttin, whichwas set to 100%.
To investigate the influence of dehydration on barttin palmi-
toylation, mice had either free access to tap water (normal con-
dition) or were deprived of water for 24 h (dehydrated condi-
tion) before kidney extirpation. We further studied barttin
palmitoylation under a high salt diet for 7 days, where animals
had free access to water and food that was balanced in all
respects except for high sodium chloride content (4% NaCl;
Ssniff, Soest, Germany) (33). Control animals were fed with a
standard diet (0.3% NaCl). Animal care and experimentation
were approved by the local animal ethics committee and carried
out in accordance with National Institutes of Health Principles
and Guidelines for the Care and Use of Laboratory Animals.
Electrophysiology and Data Analysis—For electrophysiologi-
cal experiments, HEK293T cells were co-transfected with 2 g
of pcDNA3.1 plasmid DNA encoding human barttin-mCFP
and 2g of pSVLplasmidDNAencoding hClC-Ka or hClC-Kb.
Only fluorescent cells were used for electrophysiological
recordings. Standard whole-cell patch clamp recordings were
performed typically 1 day after transfection using an Axopatch
200B amplifier (Molecular Devices, Sunnyvale, CA). Pipettes
were pulled from borosilicate glass (Harvard Apparatus, Holli-
ston, MA) with resistances of 1.0–2.0 megaohms. For noise
analyses, pipettes were covered with dental wax to reduce their
capacitance. Agar bridges were used to connect the amplifier
and the bath solution. 90–95%of the series resistancewas com-
pensated by an analog procedure. Cells were clamped to 0 mV
for 1–7 s between test sweeps. The standard extracellular solu-
tion contained 140mMNaCl, 4mMKCl, 2mMCaCl2, 0.5–1mM
MgCl2, 5 mM HEPES, pH 7.4. The standard intracellular solu-
tion contained 120mMNaCl, 2mMMgCl2, 5mM EGTA, 10mM
HEPES, pH 7.4. Patch clamp recordings were performed as
described using standard intra- and extracellular solutions at
least 1 day after transfection.
Data were analyzed using a combination of Clampfit (Axon
Instruments, Union City, CA) and SigmaPlot (Systat Software
Inc., San Jose, CA) programs. Todetermine the unitary conduc-
tances as well as absolute open probabilities of hClC-Ka/barttin
channels, stationary noise analysis was performed as described
previously (29, 34). Currents were filtered at 10 kHz and digi-
tized with a sampling rate of 50 kHz. Current variances were
corrected for the background variance thatwasmeasured at the
reversal potential (Vr5 mV).
Ion channels generate a Lorentzian type of noise (2) that
depends on the number of channels (N), the unitary current
amplitude (i), and the absolute open probability (p),
4 The abbreviations used are: MDCK Madin-Darby canine kidney; CFP, cyan
fluorescent protein; mCFP, monomeric CFP; ABE, acyl-biotinyl exchange.
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2  Ni2p(1 p) (Eq. 1)
Implementing the macroscopic current amplitude (I, with I 
Nip), Equation 1 can be modified to
2  iI
I2
N
(Eq. 2)
or
2
I
 i
I
N
(Eq. 3)
In the case of non-stationary noise analysis at a fixed potential,
fitting parabolic functions to variance versus current plots (35)
or linear functions to 2/I versus current plots (36) provides
unitary current amplitudes (i) and the number of active chan-
nels (N). The very fast deactivation of hClC-Ka/barttin chan-
nels at negative potentials (29) makes non-stationary noise
analysis difficult, and we, therefore, applied a modification of
steady-state noise analysis. We determined steady-state cur-
rent variances and steady-state current amplitudes for various
voltages and normalized the current variance by the product of
the mean current amplitude (I) and the electrical driving force
(VVr) and plotted this quotient versus the macroscopic con-
ductance (I/(V Vr)),
2
I(V Vr)

i
(V Vr)

1
N

I
(V Vr)
(Eq. 4)
Because the unitary conductance  i/(VVr) is constant for
hClC-Ka/barttin channels (29, 34), Equation 4 simplifies to
2
I(V Vr)
 
1
N

I
(V Vr)
(Eq. 5)
In such a plot the negative inverse slope of the linear regression
reveals the number of active channels in the cell membrane,
and the y axis intercept represents the unitary channel conduc-
tance ().
Biochemical Analysis of Protein Expression and Surface
Membrane Insertion—Expression of barttin and CLC-K chan-
nels was analyzed using transiently transfected MDCK II cells.
Cells were lysed by incubation in 1% Triton X-100 in the pres-
ence of protease inhibitors (Sigma). Cleared lysates were dena-
tured for 15 min at room temperature in SDS sample buffer
containing 100 mM dithiothreitol and electrophoresed in par-
allel with fluorescence mass markers (Dual Color; Bio-Rad) on
12% SDS-polyacrylamide gels. mCFP-tagged barttin and YFP-
tagged hClC-Kawere visualized by scanning the wet PAGE gels
with a fluorescence scanner (Typhoon; GE Healthcare). Fluo-
rescence intensities of individual bands were quantified with
the ImageQuant software (GE Healthcare).
For analysis of cell surface expression of CLC-K/barttin chan-
nels, MDCK II cells were incubated for 40 min with 0.25 mg of
biotin (EZ link sulfo-NHS-SS-biotin; Pierce) before cell lysis (28,
37). Biotinylated proteins were purified using NeutrAvidin
affinity chromatography (Pierce) and separated by electropho-
resis on 12% SDS-polyacrylamide gels. Fluorescence scans of
the gels revealed the relative amounts of membrane-inserted
YFP-hClC-Ka channels in the presence of WT and mutant
barttin-mCFP. Contamination of purified protein fractions by
intracellular proteins was checked by Western blots of the gels
with mouse anti-GAPDH (GeneTex Inc.). Results were taken
only from experiments without GAPDH detection.
ConfocalMicroscopy—Live cell confocal imaging was carried
outwith transiently transfectedMDCK II cells grownon special
confocal tissue culture-treated dishes (Ibidi, Martinsried, Ger-
many). Confocal imageswere obtained after 2–3days of expres-
sion of fluorescent barttin-mCFP and YFP-hClC-Ka using a
Leica DM IRB confocal microscope with a TCS SP2AOBS scan
head (Leica Microsystems, Wetzlar, Germany).
Data are shown as themeans S.E. Unpaired Student’s t test
was performed to prove statistical significance of differences in
mean values.
Results
Barttin Is Palmitoylated at Cysteine Residues Cys-54 and
Cys-56—To test whether human barttin is palmitoylated we
metabolically labeled recombinant mCFP-tagged barttin with
[3H]palmitate in HEK293T cells. After lysis and immunopre-
cipitationwith polyclonal antibodies againstGFP,we resolved a
single [3H]palmitate-bound protein band after SDS-PAGE and
fluorography (Fig. 1A). This protein co-migrated with barttin-
mCFP, as detected by fluorescence imaging, demonstrating
that barttin is palmitoylated in heterologous expression
systems.
FIGURE 1. Barttin is palmitoylated in heterologous expression systems
and in native cells. A, HEK293T cells expressing barttin-mCFP were labeled
with [3H]palmitate and subjected to immunoprecipitationwith anti-GFP anti-
bodies followed by SDS-PAGE and fluorography after 7 days exposure (right
panel). Expression of barttin-mCFP was documented by fluorescence detec-
tion (left panel). Representative results from one of two independent experi-
ments are shown. B, representative ABE analysis of barttin palmitoylation in
mouse kidneys at postnatal day 30 followed by SDS-PAGE and Western blot.
Hydroxylamine (plus NH2OH) cleaves the thioester bond between a cysteine
residue and palmitate and allows incorporation of biotinylated analog of
palmitate to the newly available thiol group that can be detected byWestern
blot. The samples without hydroxylamine (minus NH2OH) function as a neg-
ative control for specific palmitoyl-biotinylation. Shown is a representative
blot from three independent experiments.
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We then used a modified proteomic ABE technique (32) to
analyze barttin palmitoylation in native renal cells. This tech-
nique does not requiremetabolic labeling of cells or tissues and,
therefore, permits identification of protein palmitoylation in
their native surrounding. The ABE technique is based on the
cleavage of thioester linkages between cysteines and palmitates
by hydroxylamine (NH2OH). Cleavage of the thioester link
allows the specific incorporation of a biotinylated analog of
palmitate (HPDP-biotin) to the newly available thiol group and
permits detecting biotinylated palmitate analogs by Western
blotting. Using this approach we could demonstrate in vivo
posttranslational palmitoylation of endogenous barttin in
mouse kidneys (Fig. 1B).
The predicted barttin topology consists of two transmem-
brane helices, a short intracellular N terminus and a long intra-
cellular C terminus (1, 9) (Fig. 2A). There are six cysteine resi-
dues that are all located within the C terminus. To identify
potential palmitoylation sites, we took advantage of a recently
characterized disease-associated truncation mutation of bart-
tin, E88X (28), that removes four of the six cysteines. Upon
heterologous expression in HEK293T cells, no differences in
palmitoylation levels of WT and E88X barttin were observed
(Fig. 2, B and C). This finding demonstrates that the four cys-
teines C terminal to Glu-88 are not used as palmitoylation sites.
The remaining two endogenous cysteines, Cys-54 and Cys-
56, are localized close to the second transmembrane helix and
are highly conserved (Fig. 2A). We next individually or jointly
mutated these residues, Cys-54 and Cys-56, to serines in the
non-truncated barttin-mCFP background and tested the con-
sequences on barttin palmitoylation usingABE. Individual sub-
FIGURE 2. Identificationof twopalmitoylation sites in barttin.A, putative topology of barttin (upper panel) and amino acid sequence of barttin surrounding
highly conserved cysteine residues Cys-54 and Cys-56 for different species (lower panel). B–E, representative images of the ABE assay and quantitative analysis
of palmitoylation for WT and E88X barttin (B and C) and for WT, C54S, C56S, and C54S/C56S (D and E). Palmitoylation levels were calculated by comparison of
corresponding samples with and without NH2OH (negative control) treatment after normalization to the expression level. Data represent the means S.E.
from three independent experiments. *, p 0.05; **, p 0.01; ***, p 0.001). We observed a low intensity unspecific band with amolecular mass of50 kDa
(marked by an arrow in B) in all experiments with WT and mutant barttin-mCFP.
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stitutions of Cys-54 or Cys-56 resulted in significant reduction
of barttin palmitoylation to 38.0 13.9%or 74.5 1.4% (n 3),
respectively. When both cysteines were mutated simultane-
ously, barttin palmitoylation was completely abolished (Fig. 2,
D and E). We conclude that both Cys-54 and Cys-56 represent
palmitoylation sites of human barttin.
Barttin Palmitoylation Is Necessary for CLC-K/barttin
Currents—Fig. 3 shows representative whole-cell current
recordings of human hClC-Ka and hClC-Kb channels in the
absence of barttin or co-expressed with WT or non-palmitoy-
lated C54S/C56S barttin in HEK293T cells. For these record-
ings the membrane potential was held at 0 mV, and voltage
steps between155 mV and125 mV were applied, each fol-
lowed by a fixed step to 120 mV. In agreement with earlier
results (1, 10, 12), expression of hClC-Ka and hClC-Kb only
results in measurable chloride currents when co-expressed
with barttin (Fig. 3,A andB). Currents increase instantaneously
upon voltage steps in the presence of WT barttin. Whereas
single point mutations at positions Cys-54 or Cys-56 reduced
current amplitudes, C54S/C56S barttin abolished hCLC-K/
barttin currents (Fig. 3, C and D). The voltage dependence of
hCLC-K/barttin currents was not affected. A plot of palmitoy-
lation levels of different barttin mutants and corresponding
hClC-Ka/barttin and hClC-Kb/barttin current amplitudes
shows a linear relationship between barttin palmitoylation and
chloride current amplitudes (Fig. 3, C and D, insets).
Barttin Palmitoylation Does Not Modify Unitary Channel
Properties of CLC-K/barttin—Reduced whole-cell currents
might be caused by impaired protein translation, stability, or
intracellular transport or by changes in channel function. We
employed stationary noise analysis to determine unitary prop-
erties of hClC-Ka/barttin channels in the presence of WT or
mutant barttin (Fig. 4A). Because the double mutant C54S/
C56S reduced hClC-K/barttin currents to levels that are too
small to be reliably evaluated, we restricted this analysis to bart-
tinmutants with only one palmitoylation site, i.e.C54S or C56S
barttin. Plotting the current variances 2, normalized by the
product of themean current amplitude I and the electrical driv-
FIGURE 3. Mutations that reduce barttin palmitoylation decrease macroscopic CLC-K/barttin currents. A and B, voltage protocol and representative
current recordings from HEK293T cells expressing hClC-Ka (A) or hClC-Kb (B) channels in the presence of WT barttin or mutant C54S/C56S barttin. C and D,
voltage dependence ofmean current amplitudes obtained fromHEK293T cells expressing hClC-Ka (C) or hClC-Kb channels (D) in the presence ofWT barttin or
mutant barttin (C: WT, n 26; C54S, n 11; C56S, n 21; C54S/C56S, n 14; D: WT, n 13; C54S, n 7; C56S, n 7; C54S/C56S, n 11). Insets display plots
of current amplitudes at105 mV versus palmitoylation level for WT and mutant barttin.
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ing force V  Vr, versus the macroscopic conductance I/(V 
Vr) displays a linear relationship (Fig. 4B). In such a plot the y
axis intercept gives the unitary channel conductance, and the
slope of the linear regression corresponds to the number of
active channels in the plasma membrane (N  1/slope) (29,
34). The unitary current conductance of hClC-Ka/barttin chan-
nels remained unaffected by the barttin mutations (Fig. 4C).
Absolute open probabilities were calculated by dividing the
macroscopic current amplitude by the number of channels and
the single channel current amplitude (Fig. 4D). Neither abso-
lute open probabilities nor voltage dependence of hClC-Ka
activation was affected by the modified barttin subunits. We
conclude that palmitoylation of barttin modifies the number of
active channels in the plasma membrane but leaves CLC-K/
barttin channel properties unaffected.
Barttin Palmitoylation neither Affects CLC-K Channel Bio-
genesis nor Intracellular Trafficking—We next tested the
potential effects of barttin palmitoylation on its subcellular dis-
tribution and the trafficking of hClC-K/barttin channels. We
first analyzed the intracellular distribution of barttin-mCFP by
confocal microscopy, either expressed alone or together with
YFP-hClC-Ka channels in MDCK II cells. WT and single-
palmitoylated barttin mutants, C54S or C56S, were properly
inserted into the surface membrane (Fig. 5A), and even the
FIGURE 4. Barttin palmitoylation does not modify unitary current ampli-
tudesor absoluteopenprobabilities of hClC-Ka/barttin channels.A, volt-
age protocol for stationary noise analyses and representative current record-
ings of hClC-Ka co-expressed with WT or mutant barttin. B, plot of the
variance (2), normalized by the product of themean current (I) and the elec-
trical driving force (V Vr), versus the macroscopic conductance I/(V Vr). A
linear fit provides the unitary conductance as the y axis intercept and the
number of channels as the inverse slope. C and D, unitary conductances (C)
and absolute open probabilities (D) of hClC-Ka/barttin channels forWT, C54S,
andC56Sbarttin (C,WT,n9; C54S,n6; C56S,n8;D,WT,n9; C54S,n
11; C56S, n 8).
FIGURE 5.Barttin palmitoylationdoes not affect the expression and subcel-
lular distribution of hClC-Ka/barttin channels. A and B, confocal images of
MDCK II cells expressing barttin-mCFP alone (green) (A) or together with YFP-
hClC-Ka (red) (B). Scale bars represent 10m. C andD, expression levels ofWT or
mutant barttin-mCFP (C) and co-expressed YFP-hClC-Ka (D) obtained from rela-
tive fluorescence values in SDS-PAGE gels of total cleared cell lysates. Cells were
transfectedwithequalamountsofplasmidDNA.DatarepresentthemeansS.E.
fromat least 6 experiments inC and at least 12 experiments inD. E, fluorescence
scan (upper panel) of an SDS-PAGE gel of YFP-ClC-Ka present in the total cleared
lysate and the purified surface proteins when expressed together with WT or
mutant barttin. Different protein bands correspond to complex-glycosylated (#)
as well as core-glycosylated (E) or non-glycosylated (●) YFP-hClC-Ka. Western
blot analysis of the gel using anti-GAPDH antibodies (WB, lower panel) validates
exclusive biotinylation of surface membrane proteins. F, fractions of complex
(white)-, core (gray)-, and non (black)-glycosylated YFP-hClC-Ka in whole cell
lysates of HEK293T cells co-expressing WT or mutant barttin. Data are the
means S.E. from at least six experiments. G, surface-biotinylated YFP-hClC-Ka
quantified by YFP fluorescence and normalized to WT barttin from cells co-ex-
pressingWT ormutant barttin. Data represent themeans S.E. from at least 10
experiments.
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double mutant C54S/C56S was well expressed and clearly
membrane-associated. Moreover, all mutant barttins effec-
tively promoted trafficking of hClC-Ka channels to the plasma
membrane (Fig. 5B).
We next compared the total expression of channel subunits
in cells co-expressing hClC-Ka withWT ormutant barttin.We
found that the tested mutations neither modified expression
levels of barttin nor of co-expressed hClC-Ka (Fig. 5, C and D).
SDS-PAGE gels display three fluorescent bands corresponding
to complex-glycosylated (mature), core-glycosylated, and non-
glycosylated YFP-hClC-Ka (Fig. 5E) (28). CLC-K channels are
predominantly non- or core-glycosylated when expressed
alone (28), and co-expressionwith barttin increases the amount
of the complex-glycosylated pore-forming subunit. The relative
amount of the distinct glycosylation states was similar upon
co-expression with WT or mutant barttin (Fig. 5F). We next
determined the percentage of surface membrane-inserted
hClC-Ka from the fraction of proteins that was accessible to
biotinylation from the extracellular side before cell lysis. The
percentage of complex-glycosylated hClC-Ka was increased in
the biotinylated fraction as compared with the full cell lysate.
However, we also found non-glycosylated as well as core-glyco-
sylated hClC-Ka proteins in the surface membrane (Fig. 5E).
These results, which are closely similar to our previous results
on CLC-K/barttin (28), indicate that CLC-K proteins can also
insert into the plasma membrane in their non-complex-glyco-
sylated form. These findings are in full agreement with results on
other membrane proteins (38, 39).We routinely checked the sur-
facemembrane fraction for contamination with intracellular pro-
teins by Western blots of the gels using anti-GAPDH antibodies
(Fig. 5E, lower panel). There is clear antibody labeling of GAPDH
in the whole cell lysate (t), but such a signal is absent in the bioti-
nylated protein fraction of the surface membrane (s).
The fractions of surface membrane inserted channels
showed slight but insignificant reduction when hClC-Ka was
co-expressedwith doublemutant C54S/C56S barttin instead of
WT barttin (Fig. 5G). This effect, however, was too small to
explain the radical decline of current amplitudes. Palmitoylation-
deficient barttin mutants reduce the amplitude of whole-cell
hClC-Ka currents, whereas the subcellular trafficking and the
number of channels inserted in the surfacemembranewere virtu-
ally unaltered. We conclude that the pronounced current reduc-
tion in cells expressing non-palmitoylated barttin results from
insertion of constitutively closed hClC-Ka/barttin channels into
the surfacemembrane. Barttinmutants with only one palmitoyla-
tion site (C54S orC56S) release some channels from their inactive
state and give rise to small chloride conductance with unaltered
unitary channel properties. Because stably closed channels do not
influence macroscopic current variance, this conclusion is in
agreement with our results from noise analysis.
Disease-associated BSNDMutations Affect Palmitoylation of
Barttin—Mutations in BSND, the gene encoding barttin, cause
Bartter syndrome type IV, an inherited disease characterized by
severe impairment of urinary concentration ability and senso-
rineural deafness (40, 41). We recently reported that various
point mutations in BSND result in impaired CLC-K/barttin
channel activity without dramatic changes in subcellular distri-
bution (4, 28, 29). Because of the similar effects of palmitoyla-
tion-deficient and disease-associated mutants, we reasoned
that certain naturally occurring mutations might impair
palmitoylation.
We tested three disease-associated barttin mutations (R8W,
G10S, and G47R) for their possible deficiencies in palmitoyla-
tion. G47R exerted the most pronounced effect on barttin palmi-
toylation and reduced relative palmitoylation to 12.3 3.0% (n
3) of WT values. Although palmitoylation of R8W barttin was
reduced to 44.6  7.2% (n  3), there was no effect of the G10S
mutation (Fig. 6). We conclude that some, but not all disease-
causing BSNDmutations affect palmitoylation of barttin.
Changes in Barttin Palmitoylation upon Increased or
Decreased Water Intake—The inner medullar osmolarity of the
kidney is crucially dependent on the chloride permeability of the
thin and the thick ascending limb of Henle’s loop. Regulated
palmitoylation (for example, under water shortage) might, there-
fore, stimulate urinary concentration and reduce water excretion.
We thus tested the effect of water deprivation or increased water
intake upon salt diet on barttin palmitoylation levels.
In experiments testing the effect of reduced water intake
barttin palmitoylation was quantified in kidneys from mice
deprived of water for 1 day and compared with normally
hydrated control animals. Dehydration slightly increased the
level of barttin palmitoylation as compared with control ani-
mals with no water restriction, whereas the expression level of
barttin remained unaffected (Fig. 7, A-C). However, when ani-
mals were fed with high salt diet (4% NaCl for 7 days) resulting
in 2-fold water intake without any change in body weight, ele-
vated diuresis was not related to significant changes in barttin
palmitoylation or expression (Fig. 7, D–G). We conclude that
FIGURE 6. Disease-causing mutations affect palmitoylation of barttin. A,
representative image from ABE palmitoylation assay followed by SDS-PAGE
andWestern blot forWT, G10S, G47R, and R8Wbarttin. B, relative palmitoyla-
tion levels ofWT andbarttinmutants. Data are given as themeans S.E. from
three independent experiments. *, p 0.05; **. p 0.01.
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changes inwater intake do not significantly alter palmitoylation
of barttin.
Discussion
Here we demonstrate that barttin, the accessory subunit of
CLC-K channels, is palmitoylated in vivo as well as in vitro (Fig.
1). Two cysteine residues, Cys-54 and Cys-56, localized at the
junction between the second transmembrane helix and the
cytoplasmic C terminus, represent palmitoylation sites of bart-
tin (Fig. 2). Expression of palmitoylation-deficient barttin
mutants caused a dramatic reduction of macroscopic current
amplitudes (Fig. 3). The changes in current amplitudes are not
due to altered subcellular trafficking or membrane insertion
(Fig. 5) but rather result from impaired function of CLC-K/
barttin channels in the presence of non-palmitoylated barttin.
We conclude that hClC-K channels are switched into an active
state by palmitoylated barttin but remain inactive with palmi-
toylation-deficient barttin mutants.
In the past 2-bromo-palmitate has often been used as phar-
macological tool to block protein palmitoylation. Unfortu-
nately, 2-bromo-palmitate exerts pleiotropic and unspecific
effects (42) so that this compound cannot be used to test the
consequences of barttin palmitoylation on CLC-K/barttin
function. We, therefore, employed mutant barttins, in which
either one of the two or both palmitoylation sites were
removed, to test the functional impact of this posttranslational
modification. These mutations reduce or even abolish barttin
palmitoylation (Fig. 2). It appears possible that the substitution
of cysteine by serine by itself changes the function of CLC-K/
barttin channels. The following two reasons argue against this
possibility. Serine and cysteine side chains are very similar, and
it thus appears unlikely that their exchange affects the confor-
mation of barttin and the CLC-K/barttin association. Accord-
ingly, we did not observe alterations in single channel proper-
ties and voltage dependence of hClC-Ka co-expressed with
single mutant barttin. Moreover, the chaperone function of bart-
tin, promoting CLC-K channel insertion into the plasma mem-
brane, remainedunaffected.Acomparisonof theeffects of the two
single mutations and the double mutation on barttin palmitoyla-
tion andmacroscopic current amplitudes demonstrates that these
twovalues are proportional to eachother (Fig. 3). This finding is in
full agreement with the notion that the mutations decrease chlo-
ride currents by affecting barttin palmitoylation.
Impaired barttin palmitoylation leaves subcellular distribu-
tion of CLC-K and barttin unaltered (Fig. 5) but reduces mac-
roscopic current amplitudes significantly (Fig. 3). These two
results indicate that a smaller percentage of CLC-K/barttin
channels is simultaneously active. At first glance this conclu-
sion appears to be in disagreement with the results of noise
FIGURE 7. Barttin palmitoylation is only slightly modified by the hydration status. A, representative image of barttin palmitoylation in kidneys from
dehydrated and control mice as assessed by ABE assays followed by SDS-PAGE andWestern blot. B and C, relative palmitoylation (B) and expression levels (C)
of barttin in kidneys of dehydrated and control mice. Data represent themeans S.E. from five independent experiments. D, representative image from ABE
assays followedbySDS-PAGEandWesternblot for kidneys frommice after a high salt diet and fromcontrolmice afterNH2OH treatment. E, comparisonof body
weight andwater intake of control and testmice. F andG, relative palmitoylation (F) and expression levels (G) of barttin in the kidneys of control and testmice.
Data are given as the means S.E. from at least four independent experiments. (*, p 0. 05; ***, p 0.001).
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analysis which showed identical absolute open probabilities.
However, noise analysis only provides information about chan-
nel opening and closing within time periods of the underlying
experiments (Fig. 4). Taken together, biochemical and electro-
physiological results indicate that a lack of palmitoylation
causes long-lasting closed states or results in permanent clo-
sure of non-palmitoylated channels. Such a mechanism of
channel regulation is not novel (43); however, there are much
more examples of posttranslational modification of ion chan-
nels resulting in gradual modification of functional properties
such as open probability or unitary current amplitude.
Tajima et al. (44) recently proposed barttin binding to the B-
and J-helices of CLC-K. These two helices represent the longest
transmembrane domains in CLC channels and are tilted by
45° within the cell membrane (45). Binding of palmitate has
been proposed to result in elongation of hydrophobic protein
domains or even to tilt transmembrane helices (19, 46). Palmi-
toylation, therefore, might adjust the orientation of barttin
within the lipid bilayer. It is tempting to speculate that associ-
ation of barttin with these channel domains might result in
altered orientation and thus change channel function.
The pronounced effect of barttin palmitoylation on CLC-K/
barttin channel function suggests that this regulatory pathway
might modify chloride conductances in the thin and thick
ascending limb of the loop of Henle and permit adjusting uri-
nary concentration and water excretion to variable fluid intake.
However, we observed only minor changes in palmitoylation
levels of barttin in mice upon water deprivation or upon
increased water intake during a salt diet. For both conditions
expression levels of barttin remained unchanged. Water depri-
vation inratshasbeenpreviously reported toresult inbetween1.7-
and 4-fold up-regulation of rClC-K1, the homologue of human
hClC-Ka (6, 47).Thismaneuver thus increases expression levels of
CLC-Kproteins tomuchhigher levels thanbarttinpalmitoylation.
These findings suggest that palmitoylated barttin is excessively
available in epithelial cells of Henle’s loop so that even significant
increases in the number of CLC-K channels will result in the for-
mation of functional CLC-K/barttin channels.
We did not investigate barttin palmitoylation in distinct sec-
tions of the nephron separately. It thus appears possible that
barttin palmitoylation is regulated in certain sections of the
nephron by the water and salt intake. In contrast to up-regula-
tion of rClC-K1 in the thin ascending limb of the Henle loop,
the expression of rat rClC-K2, i.e. the homologue of human
hClC-Kb, is not altered by dehydration (47). Because chloride
conductance in the thick ascending limb of the Henle loop is
exclusively mediated by ClC-K2/Kb, its regulation under water
deprivation might be restricted to changes in barttin palmitoy-
lation. Under conditions of sufficient water supply reduced
palmitoylation of barttin may result in chloride accumulation
in the cytoplasm of the thick ascending limb epithelial cells.
This is expected to slow down the uptake of sodium chloride by
the Na/K/2Cl transporter at the apical membrane and save
energy by reducing the rate of the basolateral Na-K-ATPase.
In our experiments animals were exposed to water restric-
tion for 1 day or salt diet for 1 week. These experiments thus
only permitted identification of long term effects on palmitoy-
lation levels. Dynamic palmitoylation events that take place
within minutes or hours (48–50) might contribute to rapid
adjustment and fine tuning of urinary concentration. The iden-
tification of palmitoyl-acyl transferases, which are involved in
the posttranslational modification of barttin, might clarify the
dynamics of the process and its potential for the adaptation of
renal chloride currents.
Mutations in BSND cause Bartter syndrome type IV, a disor-
der of kidney function and hearing (1, 9, 28, 40, 41). The severity
of renal symptoms varies widely between barttinmutations (28,
29, 40, 41). In recent years we have studied the functional con-
sequences of several BSNDmutations and found a clear corre-
lation between changes in barttin function in heterologous
expression systems and the severity of the clinical symptoms (4,
28, 29). We now tested three naturally occurring disease-asso-
ciatedmutations and observed distinct alterations in posttrans-
lational modification of mutant barttin.
G47R results in sensorineural deafness in all patients and
causes kidney disease of varying severity. Whereas initial
reports describe a lack of characteristic renal symptoms as poly-
hydramnios, premature labor, or severe salt loss in neonatal
period in patients carrying the G47R mutation (51–53), later
work demonstrated that this mutation can also result in end-
stage renal disease (54). In heterologous expression systems,
G47R did not abolish activation of hClC-Kb/barttin channels
but reduced macroscopic currents to 10–15% as compared
with WT barttin without affecting membrane insertion (28).
We now demonstrate that palmitoylation of G47R barttin is
decreased to a very similar extent (to 12.3 3.0% (n 3) ofWT
barttin). Taken together, these results suggest that G47Rmight
exert its effects on barttin function at least partially via changes
in palmitoylation. When heterologously expressed together
with hClC-Ka or hClC-Kb in mammalian cells, R8W and G10S
result in reduction ofmacroscopic current amplitudes by90%
(28). Our results now demonstrate that R8W reduce barttin
palmitoylation to 44.6 7.2% (n 3), whereas G10S leaves this
modification unaffected (Fig. 6). These mutations most likely
cause chloride channel dysfunction independently of barttin
palmitoylation, for example by conformational changes that
impair the interaction with CLC-K channels.
In summary, here we demonstrate that barttin palmitoyla-
tion almost exclusively affects the function of CLC-K/barttin
channels and thus may permit a rapid and reversible regulation
of epithelial chloride conductance. Approaches that interfere
with barttin palmitoylation might allow the development of
novel diuretic agents for anti-hypertensive treatment.
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